JP2015129189A5 - - Google Patents

Download PDF

Info

Publication number
JP2015129189A5
JP2015129189A5 JP2015077340A JP2015077340A JP2015129189A5 JP 2015129189 A5 JP2015129189 A5 JP 2015129189A5 JP 2015077340 A JP2015077340 A JP 2015077340A JP 2015077340 A JP2015077340 A JP 2015077340A JP 2015129189 A5 JP2015129189 A5 JP 2015129189A5
Authority
JP
Japan
Prior art keywords
composition
mucositis
ulcer
inflammation
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015077340A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015129189A (ja
JP6000397B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015129189A publication Critical patent/JP2015129189A/ja
Publication of JP2015129189A5 publication Critical patent/JP2015129189A5/ja
Application granted granted Critical
Publication of JP6000397B2 publication Critical patent/JP6000397B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015077340A 2010-04-06 2015-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物 Active JP6000397B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32143710P 2010-04-06 2010-04-06
US61/321,437 2010-04-06
US201161451430P 2011-03-10 2011-03-10
US61/451,430 2011-03-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013503881A Division JP2013523827A (ja) 2010-04-06 2011-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015237188A Division JP2016033164A (ja) 2010-04-06 2015-12-04 キトサン化合物を用いて創傷を処置するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2015129189A JP2015129189A (ja) 2015-07-16
JP2015129189A5 true JP2015129189A5 (enExample) 2016-01-28
JP6000397B2 JP6000397B2 (ja) 2016-09-28

Family

ID=44763261

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2013503881A Pending JP2013523827A (ja) 2010-04-06 2011-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2015077340A Active JP6000397B2 (ja) 2010-04-06 2015-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2015237188A Withdrawn JP2016033164A (ja) 2010-04-06 2015-12-04 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2017194973A Withdrawn JP2017226706A (ja) 2010-04-06 2017-10-05 キトサン化合物を用いて創傷を処置するための方法および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013503881A Pending JP2013523827A (ja) 2010-04-06 2011-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015237188A Withdrawn JP2016033164A (ja) 2010-04-06 2015-12-04 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2017194973A Withdrawn JP2017226706A (ja) 2010-04-06 2017-10-05 キトサン化合物を用いて創傷を処置するための方法および組成物

Country Status (7)

Country Link
US (5) US9439925B2 (enExample)
EP (1) EP2555760B1 (enExample)
JP (4) JP2013523827A (enExample)
AU (1) AU2011237682B2 (enExample)
CA (1) CA2795520C (enExample)
ES (1) ES2773017T3 (enExample)
WO (1) WO2011127144A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119780B2 (en) 2006-06-02 2012-02-21 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
EP3311823B1 (en) 2009-09-02 2020-11-25 Synedgen, Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
EP2555760B1 (en) 2010-04-06 2019-10-16 Synedgen, Inc. Chitosan derivatives for the treatment of mucositis or ulceration
WO2013134129A2 (en) * 2012-03-05 2013-09-12 Synedgen, Inc. Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins
CN102755662B (zh) * 2012-07-25 2014-01-08 福州乾正药业有限公司 一种复合壳聚糖凝胶膜及其制备方法
CA2883704C (en) * 2012-09-20 2021-09-28 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
TWI478943B (zh) * 2012-12-27 2015-04-01 Ind Tech Res Inst 高分子組成物用於製備具有抑制基質金屬蛋白酶之活性的功效的醫療器材或抑制劑的用途
CN103893813B (zh) * 2012-12-28 2018-04-17 财团法人工业技术研究院 高分子组合物与高分子材料
WO2014165226A2 (en) 2013-03-12 2014-10-09 Synedgen, Inc. Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
JP2016519667A (ja) * 2013-03-15 2016-07-07 シネジェン, インコーポレイテッド 創傷治癒のための組成物および使用方法
WO2015022907A1 (ja) * 2013-08-13 2015-02-19 生化学工業株式会社 カチオン化キトサンを含有する医薬
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
EP3190886B1 (en) 2014-09-11 2024-04-10 Synedgen, Inc. Compositions for use in the treatment of acute respiratory distress syndrome
WO2017072236A1 (en) * 2015-10-30 2017-05-04 Croma-Pharma Gesellschaft M.B.H. Therapeutic use of a sterile aqueous ophthalmic solution
CN108348457A (zh) * 2015-10-30 2018-07-31 克罗马药品股份有限公司 无菌水性眼用溶液的治疗用途
WO2017161113A1 (en) * 2016-03-16 2017-09-21 Synedgen, Inc. Compositions and methods of their use
CN108096182A (zh) * 2016-11-25 2018-06-01 哈尔滨盈聚生物科技有限公司 一种基于绿色抗菌材料的妇科抗菌凝胶及其制备方法
US10918699B2 (en) * 2017-03-22 2021-02-16 Michael C. Struck Therapeutic treatment for neurotrophic keratopathy
EP3618803A1 (en) 2017-05-03 2020-03-11 Croma-Pharma GmbH Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
TWI633888B (zh) * 2017-10-03 2018-09-01 黃琮瑋 醣類物質用於製備改善嗅覺功能的藥物之用途
CN107970269A (zh) * 2017-12-30 2018-05-01 广州润虹医药科技股份有限公司 一种含有壳聚糖的口腔溃疡膜及其制备方法
RU2697869C1 (ru) * 2018-04-28 2019-08-21 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Фармацевтическая субстанция для лечения инфицированных ран различного генеза
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP4406542A1 (en) 2023-01-26 2024-07-31 BioKuris Treatment of gut inflammatory diseases

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4532134A (en) 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
CA2181048C (en) * 1994-01-14 2003-05-06 Lee Shahinian, Jr. A method for sustained and extended corneal analgesia
US7214202B1 (en) 1997-07-28 2007-05-08 Kci Licensing, Inc. Therapeutic apparatus for treating ulcers
CA2659664C (en) 1998-03-10 2013-05-07 University Of Southern California Improved radiation therapy methods
WO2000005974A1 (en) 1998-07-30 2000-02-10 E-Nutriceuticals, Inc. Novel chitosan-containing liquid compositions and methods for their preparation and use
US6114382A (en) 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
ATE285751T1 (de) * 1998-11-20 2005-01-15 Medidom Lab Wässrige ophthalmische formulierungen mit chitosan
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
JP2003012702A (ja) * 2001-04-24 2003-01-15 Sankyo Co Ltd 低分子キトサンの製造方法
CA2493083C (en) 2002-07-16 2012-11-06 Bio Syntech Canada Inc. Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
GB0302741D0 (en) 2003-02-06 2003-03-12 Advanced Biopolymers As Use
GB0303085D0 (en) 2003-02-11 2003-03-19 Pfizer Ltd Model
BRPI0513604A (pt) * 2004-07-26 2008-05-13 Kci Licensing Inc método para revestir uma espuma para a colocação em um sìtio da ferida e método para tratar uma ferida
CN1965650A (zh) 2005-11-14 2007-05-23 陈祖辉 多元金属离子螯合的甲壳素绿色抗菌剂
US8119780B2 (en) 2006-06-02 2012-02-21 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
SG10201604530SA (en) 2008-01-22 2016-07-28 Araim Pharmaceuticals Inc Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
EP2296676B1 (en) * 2008-05-09 2016-11-02 Regenics AS Cellular extracts
WO2010021930A1 (en) * 2008-08-16 2010-02-25 Synedgen, Inc. Prevention and treatment of mrsa infections with chitosan-derivatives
CA2732438A1 (en) 2008-08-29 2010-03-04 The General Hospital Corporation Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
WO2010056927A1 (en) 2008-11-12 2010-05-20 Synedgen, Inc. Chitosan derivatives alone or in combination for the treatment of mdr microbial infections
US8399635B2 (en) 2008-11-12 2013-03-19 Synedgen, Inc. Chitosan derivatives to treat animals or optimize animal health
CA2751268A1 (en) 2009-01-29 2010-08-05 Synedgen, Inc. Nucleic acid delivery using modified chitosans
RU2011152518A (ru) 2009-06-10 2013-07-20 Экстера Аб Применение композиции для лечения мукозита
EP2473043B1 (en) 2009-09-02 2020-03-25 Synedgen, Inc. Oral care methods and compositions utilizing chitosan-derivative compounds
EP3311823B1 (en) * 2009-09-02 2020-11-25 Synedgen, Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
EP2555760B1 (en) 2010-04-06 2019-10-16 Synedgen, Inc. Chitosan derivatives for the treatment of mucositis or ulceration
US20140221308A1 (en) 2011-07-01 2014-08-07 Synedgen, Inc. Methods and compositions of reducing and preventing bacterial growth and the formation of biofilm on a surface utilizing chitosan-derivative compounds
US8735571B2 (en) 2011-12-22 2014-05-27 Agenta Biotechnologies, Inc. Composition, preparation, and use of dense chitosan membrane materials
WO2013134129A2 (en) 2012-03-05 2013-09-12 Synedgen, Inc. Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins
CA2883704C (en) 2012-09-20 2021-09-28 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
WO2014165226A2 (en) 2013-03-12 2014-10-09 Synedgen, Inc. Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
JP2016519667A (ja) 2013-03-15 2016-07-07 シネジェン, インコーポレイテッド 創傷治癒のための組成物および使用方法
EP3190886B1 (en) 2014-09-11 2024-04-10 Synedgen, Inc. Compositions for use in the treatment of acute respiratory distress syndrome
EP3618803A1 (en) 2017-05-03 2020-03-11 Croma-Pharma GmbH Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
US11390408B2 (en) 2020-11-24 2022-07-19 Axon Llc System and method for applying tubular bands to containers utilizing angled band ejection

Similar Documents

Publication Publication Date Title
JP2015129189A5 (enExample)
JP2010534236A5 (enExample)
JP2010501596A5 (enExample)
WO2018152353A3 (en) Pentaaza macrocyclic ring complexes for local intestinal delivery
JP2017515888A5 (enExample)
JP2007500176A5 (enExample)
Iwama et al. A novel finding of Rapunzel syndrome
JP2014525749A5 (enExample)
JP2015534956A5 (enExample)
Khurana A Speedy Recovery with Medical Management in a Patient with Emphysematous Gastritis
JP2011153102A (ja) 有機酸重合体を有効成分とするクローン病の予防又は治療剤
Rodríguez et al. Upper gastrointestinal bleeding due to gastric and duodenal Kaposi's sarcoma
Rashid et al. Occult Gastrointestinal Bleeding Secondary to Gastric Amyloidosis in an HIV-Infected Patient: 103
Waintraub et al. Asymptomatic Strongyliodes Found in a Colonic Polyp: 346
Almashhrawi et al. Elmiron-induced Colitis: A Rare Complication: 344
Bolla et al. Gastrointestinal Profile and Efficacy in Rats of the Cyclooxygenase-Inhibiting Nitric Oxide Donator (CINOD) Compound NCX 429: 104
Parkhomenko et al. Clinical and endoscopic features of the upper digestive tract pathology in children and adolescents depending on age
Kaplan et al. Acute Hemorrhagic Colitis in 25 Year Old Man Treated for Flu like Symptoms: 607
Paul Mo1657 UPPER ENDOSCOPE IS HIGHLY EFFECTIVE IN ACHIEVING COMPLETION COLONOSCOPY IN TECHNICALLY DIFFICULT AND PREVIOUS INCOMPLETE COLONOSCOPIES
Mendu et al. Isolated Gastric Malakoplakia Associated with Helicobacter Pylori Infection: A Case Report and Review of Literature: 608
Mukherjee et al. Recurrent Signet-Cell Type Gastric Cancer Simulating Ulcerative Colitis: 606
Piscaglia et al. Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome?
Siopi AB055. Long term NIV
Al-Shammari et al. Unique Endoscopic Findings ofMycobacterium Avium Complex (MAC) Colitis: 1791
Hamadah Colonic ischemia: case report